Carbon-ion radiotherapy followed by Nivolumab for primary mucosal malignant melanoma of the head and neck
Not Applicable
Recruiting
- Conditions
- mucosal malignant melanoma of the head and neck
- Registration Number
- JPRN-UMIN000042226
- Lead Sponsor
- Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with interstitial pneumonia, drug-induced interstitial lung disease or clinically active interstitial lung disease on chest CT scan 2)Patients with autoimmune disorders 3)Known allergy to compounds of similar chemical or biologic composition to Nivolumab 4)Pregnant or lactating females 5)Patients in which the physician decides that participation in the study is unsuitable
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method